Randy E. Dobbs Sells 36,261 Shares of Viemed Healthcare, Inc. (NASDAQ:VMD) Stock

Viemed Healthcare, Inc. (NASDAQ:VMDGet Free Report) Director Randy E. Dobbs sold 36,261 shares of the business’s stock in a transaction dated Wednesday, November 13th. The stock was sold at an average price of $9.28, for a total transaction of $336,502.08. Following the transaction, the director now owns 107,706 shares in the company, valued at approximately $999,511.68. The trade was a 25.19 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Viemed Healthcare Trading Down 1.0 %

Shares of Viemed Healthcare stock opened at $9.06 on Friday. The company’s fifty day moving average price is $8.31 and its two-hundred day moving average price is $7.53. The firm has a market capitalization of $352.80 million, a PE ratio of 33.56 and a beta of 1.43. Viemed Healthcare, Inc. has a 52-week low of $6.21 and a 52-week high of $10.44. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.31 and a quick ratio of 1.19.

Viemed Healthcare (NASDAQ:VMDGet Free Report) last announced its quarterly earnings results on Wednesday, November 6th. The company reported $0.10 EPS for the quarter, beating the consensus estimate of $0.08 by $0.02. Viemed Healthcare had a return on equity of 8.72% and a net margin of 4.87%. The business had revenue of $58.00 million for the quarter.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the business. Thrivent Financial for Lutherans raised its holdings in Viemed Healthcare by 0.6% during the 3rd quarter. Thrivent Financial for Lutherans now owns 3,425,693 shares of the company’s stock worth $25,110,000 after purchasing an additional 21,047 shares during the last quarter. Wasatch Advisors LP boosted its stake in Viemed Healthcare by 19.6% in the third quarter. Wasatch Advisors LP now owns 1,848,884 shares of the company’s stock valued at $13,552,000 after acquiring an additional 303,277 shares during the last quarter. Vanguard Group Inc. grew its holdings in Viemed Healthcare by 53.0% during the 1st quarter. Vanguard Group Inc. now owns 1,781,914 shares of the company’s stock worth $16,803,000 after acquiring an additional 617,009 shares during the period. Kent Lake Capital LLC acquired a new stake in Viemed Healthcare during the 1st quarter worth $5,557,000. Finally, Renaissance Technologies LLC raised its position in shares of Viemed Healthcare by 50.9% during the 2nd quarter. Renaissance Technologies LLC now owns 438,700 shares of the company’s stock valued at $2,873,000 after acquiring an additional 147,900 shares during the last quarter. 74.24% of the stock is owned by institutional investors.

Viemed Healthcare Company Profile

(Get Free Report)

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.

Further Reading

Receive News & Ratings for Viemed Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viemed Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.